Valneva has reported encouraging six-month safety and antibody persistence data from the multi-centre Phase II trial, VLA1553 ...

Valneva reports positive six-month data for Ixchiq in children, supporting a full dose approach ahead of a Phase 3 trial set ...

The strong immune response was confirmed in CHIKV-naïve children with a 96.5% seroresponse rate (full dose) at Day 180. VLA1553 was well tolerated in children aged one to eleven years regardless of ...

EmulsiPan is an oil-in-water emulsion adjuvant and is produced by nano-emulsification of squalene along with surfactants and buffers. Squalene is a naturally occurring biodegradable and biocompatible ...

and supported by the Coalition for Epidemic Preparedness Innovations (CEPI), to advance the fight against the deadly haemorrhagic Lassa Fever and accelerate the development and future equitable ...

The Trump administration is eroding national pandemic flu defenses as it guts health agencies, cuts research and health ...

Several grant awards have also been announced, including a Gates Foundation award and two Coalition for Epidemic Preparedness Innovation (CEPI) awards, which are also backed by the Gates Foundation.

Biotech Vaxxas has announced a partnership agreement with the 2017-established Coalition for Epidemic Preparedness Innovations (CEPI), in order to advance the development of Vaxxas’ needle-free ...

Bio Usawa, a private biotech company focused on boosting drug access in Africa, inked a deal with cleanroom and laboratory ...

Valneva has been awarded funding from the Coalition for Epidemic Preparedness Innovations (CEPI) and EU to expand access to its recently approved vaccine for chikungunya, a potentially life ...

The Trump administration Department of Health and Human Services has canceled a $766 million contract with Moderna to ...